Cargando…
The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication?
The natural history of patients with myelodysplastic syndrome (MDS) is dependent upon the presence and magnitude of diverse genetic and molecular aberrations. The International Prognostic Scoring System (IPSS) and revised IPSS (IPSS‐R) are the most widely used classification and prognostic systems;...
Autores principales: | Cook, Michael R., Karp, Judith E., Lai, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176033/ https://www.ncbi.nlm.nih.gov/pubmed/35846202 http://dx.doi.org/10.1002/jha2.317 |
Ejemplares similares
-
Prognostic impact of gene mutations in myelodysplastic syndromes with ring sideroblasts
por: Martín, Iván, et al.
Publicado: (2017) -
Genetics of Myelodysplastic Syndromes
por: Saygin, Caner, et al.
Publicado: (2021) -
Diagnostics and Prognostication of Myelodysplastic Syndromes
por: Zini, Gina
Publicado: (2017) -
Prognostic Markers of Myelodysplastic Syndromes
por: Veryaskina, Yuliya Andreevna, et al.
Publicado: (2020) -
Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencing
por: Xu, Yuanyuan, et al.
Publicado: (2017)